Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 Oct 12;20(12):2642–2645. doi: 10.1158/1055-9965.EPI-11-0890

Table 1.

Genotype frequencies of the TERT polymorphisms among SCCHN cases and control subjects and their associations with SCCHN risk

Genotype Cases
n = 888 (%)
Controls
n = 885 (%)
Adjusted OR(95%CI)a
rs2735940 G>A
 GG 224 (25.2) 221 (25.0) 1.00
 GA 440 (49.6) 436 (49.3) 0.99 (0.78–1.26)
 AA 224 (25.2) 228 (25.7) 1.03 (0.79–1.36)
rs2736098 C>T
 CC 481 (54.2) 468 (52.9) 1.00
 CT 351 (39.5) 356 (40.2) 0.97 (0.79–1.19)
 TT 56 (6.3) 61 (6.9) 0.86 (0.58–1.29)
rs2736109 G>A
 GG 319 (35.9) 313 (35.4) 1.00
 GA 427 (48.1) 419 (47.3) 1.00 (0.81–1.24)
 AA 142 (16.0) 153 (17.3) 0.92 (0.69–1.22)
rs2853669 T>C
 TT 428 (48.2) 425 (48.0) 1.00
 TC 381 (42.9) 375 (42.4) 1.02 (0.84–1.26)
 CC 79 (8.9) 85 (9.6) 0.91 (0.64–1.29)
rs2853677 A>G
 AA 294 (33.1) 311 (35.1) 1.00
 AG 448 (50.5) 416 (47.0) 1.09 (0.88–1.36)
 GG 146 (16.4) 158 (17.9) 1.00 (0.75–1.33)
rs2853690 G/A
 GG 596 (67.1) 618 (69.8) 1.00
 GA 265 (29.8) 228 (25.8) 1.17 (0.94–1.45)
 AA 27 (3.0) 39 (4.4) 0.69 (0.41–1.16)
a

Adjusted by age, sex, smoking and drinking status.